Noortje Thielen

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. Thielen N, Richter J, Baldauf M, Barbany G, Fioretos T, Giles F, et al. Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy. Clin Cancer Res. 2016;22:4030-8 pubmed publisher
    ..Clin Cancer Res; 22(16); 4030-8. ©2016 AACR. ..
  2. Thielen N, van der Holt B, Cornelissen J, Verhoef G, Gussinklo T, Biemond B, et al. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). Eur J Cancer. 2013;49:3242-6 pubmed publisher
    ..All evaluable patients remained sensitive to imatinib after reinitiation and regained a molecular response. Our data suggest that discontinuation of imatinib is safe in patients with durable MR(4.5). ..